Close

Dr Rosa Legood

(花罗莎) MSc DPhil

Associate Professor
of Health Economics

Room
1st Floor, Room 134

LSHTM
15-17 Tavistock Place
London
WC1H 9SH
United Kingdom

Tel.
+44 (0)207 958 8256

Fax.
+44 207 927 2701

Rosa joined LSHTM in 2007. Her training is in health economics and public health. Previously she worked at Oxford in the Department of Public Health and York Health Economics Consortium. She has specific expertise in modelling and economic evaluation.

Affiliations

Faculty of Public Health and Policy
Department of Health Services Research and Policy

Centres

Centre for Global Chronic Conditions
Centre for Global Mental Health

Teaching

 

She has supervised four PhDs to successful completion. Currently she is interested in supervising PhD students on the following topics 1) Economic evaluations of global mental health 2) Economics of breast cancer in Africa and Brazil

Research

Her main research interests relate to conducting economic evaluations in both developed and developing country settings. In addition, she is interested in the gap between the needs of policy makers and the presentation of cost-effectiveness information.  She is the health economics lead on a large RCT to tackle school bullying. She also collaborates with Queen Mary modelling genetic testing for breast and ovarian cancer prevention.

 

Research Area
Decision analysis
Economic evaluation
Health technology assessment
Vaccines
Modelling
Discipline
Health economics
Economics
Genetics
Mathematical modelling
Disease and Health Conditions
Cancer
HIV/AIDS
Mental health
Human papillomavirus (HPV)
Non-communicable diseases
Country
Burkina Faso
Brazil
China
India
South Africa

Selected Publications

Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study.
Gaba F; Blyuss O; Chandrasekaran D; Osman M; Goyal S; Gan C; Izatt L; Tripathi V; Esteban I; McNicol L
2020
BJOG : an international journal of obstetrics and gynaecology
Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and Prevention.
Gaba F; Blyuss O; Liu X; Goyal S; Lahoti N; Chandrasekaran D; Kurzer M; Kalsi J; Sanderson S; Lanceley A
2020
Cancers
Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial.
Gaba F; Robbani S; Singh N; McCluggage WG; Wilkinson N; Ganesan R; Bryson G; Rowlands G; Tyson C; Arora R
2020
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Cost-effectiveness of HPV self-sampling in cervical screening programmes in high- and upper-middle-income countries: a systematic review.
Humphreys E; Legood R; Foss A
2020
Cost-Utility Analysis of a Complex Intervention to Reduce School-Based Bullying and Aggression: An Analysis of the Inclusive RCT
Legood R; Opondo C; Warren E; Jamal F; Bonell C; Viner R; Sadique Z
2020
Value in Health
Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems.
Manchanda R; Sun L; Patel S; Evans O; Wilschut J; De Freitas Lopes AC; Gaba F; Brentnall A; Duffy S; Cui B
2020
Cancers
Costs of Early Invasive Breast Cancer in England Using National Patient-Level Data.
Sun L; Cromwell D; Dodwell D; Horgan K; Gannon MR; Medina J; Pennington M; Legood R; Dos-Santos-Silva I; Sadique Z
2020
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
See more Publications